First Header Logo Second Header Logo

Connection

Michael Gautreaux to Middle Aged

This is a "connection" page, showing publications Michael Gautreaux has written about Middle Aged.
Connection Strength

0.220
  1. Althage M, Heinrich TM, Miliotis T, Bogstedt A, Ma L, Gautreaux MD, Hicks PJ, Palmer ND, MacPhee I, Hartleib-Geschwindner J, Greasley PJ, Freedman BI. Urine APOL1 Isoforms Reflect Plasma-Derived Liver-Synthesized Proteins. J Am Soc Nephrol. 2021 Oct; 32(10):2442-2444.
    View in: PubMed
    Score: 0.019
  2. Rogers J, Farney AC, Orlando G, Harriman D, Reeves-Daniel A, Jay CL, Doares W, Kaczmorski S, Gautreaux MD, Stratta RJ. Dual Kidney Transplantation from Donors at the Extremes of Age. J Am Coll Surg. 2019 04; 228(4):690-705.
    View in: PubMed
    Score: 0.016
  3. Orlando G, Khan MA, El-Hennawy H, Farney AC, Rogers J, Reeves-Daniel A, Gautreaux MD, Doares W, Kaczmorski S, Stratta RJ. Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors? Clin Transplant. 2018 03; 32(3):e13185.
    View in: PubMed
    Score: 0.015
  4. Khan MA, El-Hennawy H, Farney AC, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta RJ. Analysis of local versus imported expanded criteria donor kidneys: A single-center experience with 497 ECD kidney transplants. Clin Transplant. 2017 08; 31(8).
    View in: PubMed
    Score: 0.014
  5. Dorr CR, Freedman BI, Hicks PJ, Brown WM, Russell GB, Julian BA, Pastan SO, Gautreaux MD, Muthusamy A, Chinnakotla S, Hauptfeld V, Bray RA, Kirk AD, Divers J, Israni AK. Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes. PLoS One. 2016; 11(4):e0152775.
    View in: PubMed
    Score: 0.013
  6. Stratta RJ, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Palanisamy A, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, El-Hennawy H, Khan M, Rogers J. Dual kidney transplants from adult marginal donors successfully expand the limited deceased donor organ pool. Clin Transplant. 2016 Apr; 30(4):380-92.
    View in: PubMed
    Score: 0.013
  7. Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND, Palanisamy A, Reeves-Daniel AM, Brown WM, Divers J. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. Transplantation. 2016 Jan; 100(1):194-202.
    View in: PubMed
    Score: 0.013
  8. Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW, Langefeld CD, Hicks PJ, Ma L, Freedman BI. Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Kidney Int. 2015 Sep; 88(3):584-92.
    View in: PubMed
    Score: 0.012
  9. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL, Palanisamy A, Reeves-Daniel AM, Divers J. Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Am J Transplant. 2015 Jun; 15(6):1615-22.
    View in: PubMed
    Score: 0.012
  10. Al-Shraideh Y, Farooq U, Farney AC, Palanisamy A, Rogers J, Orlando G, Buckley MR, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ. Influence of recipient age on deceased donor kidney transplant outcomes in the expanded criteria donor era. Clin Transplant. 2014 Dec; 28(12):1372-82.
    View in: PubMed
    Score: 0.012
  11. Singh RP, Farney AC, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Doares W, Iskandar S, Adams P, Stratta RJ. Hypertension in standard criteria deceased donors is associated with inferior outcomes following kidney transplantation. Clin Transplant. 2011 Jul-Aug; 25(4):E437-46.
    View in: PubMed
    Score: 0.009
  12. Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation. 2009 Sep 27; 88(6):810-9.
    View in: PubMed
    Score: 0.008
  13. Farney AC, Singh RP, Hines MH, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL, Stratta RJ. Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support. J Am Coll Surg. 2008 May; 206(5):1028-37; discussion 1037.
    View in: PubMed
    Score: 0.008
  14. Singh RP, Rogers J, Farney AC, Moore PS, Hartmann EL, Reeves-Daniel A, Adams PL, Gautreaux M, Stratta RJ. Outcomes of extended donors in pancreatic transplantation with portal-enteric drainage. Transplant Proc. 2008 Mar; 40(2):502-5.
    View in: PubMed
    Score: 0.008
  15. Moore PS, Farney AC, Hartmann EL, Rogers J, Doares W, Gautreaux MD, Iskandar SS, Hairston G, Adams PL, Stratta RJ. Experience with deceased donor kidney transplantation in 114 patients over age 60. Surgery. 2007 Oct; 142(4):514-23; discussion 523.e1-2.
    View in: PubMed
    Score: 0.007
  16. Moore PS, Farney AC, Sundberg AK, Rohr MS, Hartmann EL, Iskandar SS, Gautreaux MD, Rogers J, Doares W, Anderson TK, Adams PL, Stratta RJ. Dual kidney transplantation: a case-control comparison with single kidney transplantation from standard and expanded criteria donors. Transplantation. 2007 Jun 27; 83(12):1551-6.
    View in: PubMed
    Score: 0.007
  17. Stratta RJ, Moore PS, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL. Influence of pulsatile perfusion preservation on outcomes in kidney transplantation from expanded criteria donors. J Am Coll Surg. 2007 May; 204(5):873-82; discussion 882-4.
    View in: PubMed
    Score: 0.007
  18. Moore PS, Farney AC, Sundberg AK, Rohr MS, Hartmann EL, Iskandar SS, Gautreaux MD, Rogers J, Doares W, Anderson TK, Adams PL, Stratta RJ. Experience with dual kidney transplants from donors at the extremes of age. Surgery. 2006 Oct; 140(4):597-605; discussion 605-6.
    View in: PubMed
    Score: 0.007
  19. Stratta RJ, Rohr MS, Sundberg AK, Farney AC, Hartmann EL, Moore PS, Rogers J, Iskandar SS, Gautreaux MD, Kiger DF, Doares W, Anderson TK, Hairston G, Adams PL. Intermediate-term outcomes with expanded criteria deceased donors in kidney transplantation: a spectrum or specter of quality? Ann Surg. 2006 May; 243(5):594-601; discussion 601-3.
    View in: PubMed
    Score: 0.007
  20. Stratta RJ, Sundberg AK, Rohr MS, Farney AC, Hartmann EL, Roskopf JA, Iskandar SS, Hairston G, Kiger DF, Gautreaux MD, Anderson TK, Adams PL. Optimal use of older donors and recipients in kidney transplantation. Surgery. 2006 Mar; 139(3):324-33.
    View in: PubMed
    Score: 0.007
  21. Ward WG, Heise E, Boles C, Kiger D, Gautreaux M, Rushing J, Smith BP, Bullard D. Human leukocyte antigen sensitization after structural cortical allograft implantations. Clin Orthop Relat Res. 2005 Jun; (435):31-5.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.